Advanced Pleural Malignant Mesothelioma

3 clinical trials · Condition

Record	Firm	Date
Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer (NCT04491942)	National Cancer Institute (NCI)	2021-08-25
Methoxyamine, Cisplatin, and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors or Mesothelioma That Cannot Be Removed by Surgery or Mesothelioma That Is Refractory to Pemetrexed Disodium and Cisplatin or Carboplatin (NCT02535312)	National Cancer Institute (NCI)	2016-03-08
Genetically Modified T Cells in Treating Patients With Stage III-IV Non-small Cell Lung Cancer or Mesothelioma (NCT02408016)	Fred Hutchinson Cancer Center	2015-05-22

Every clearance here is in the API, with alerts when new ones post.